According to the EU directive 2001/83/EC Art.14 and EU directive 2001/82/EC Art.17 “simplified registration procedure” and EU directive 2001/83/EC Art.16 and EU directive 2001/82/EC Art.19 concerning homeopathic medicinal product for human and veterinary use the definition must take into consideration two elements: the homeopathic use and the homeopathic nature of the stock/raw material. A stock/raw material for homeopathic preparation has to be precisely described; the directives are related to the manufacturing methods. The wording “homeopathic remedy” means that it remediates a situation and the wording “homeopathic medicine" means a well defined/described stock/raw material to be used in homeopathy. In the LMHI-ECH 2009 document about “Medical Homeopathic Education Standards”, “Homeopathy” is defined as: “a method of medical practice, aimed at improving the level of health of an organism by the administration of proven and sucussed/triturated medicines, which are individually selected in accordance with the law of similars.” In order to arrive to a more complete definition for the homeopathic medicine/remedy, 3 aspects must be considered.

Dr. José Matuk, President of the Liga Medicorum Homeopathica Internationalis (LMHI) joined the celebration of the 50th anniversary of the school "Homeopatia de Mexico AC" that took place from 3 - 7 August 2010 in Mexico City. He was accompanied by LMHI Prime Vice President Dr. Renzo Galassi and the LMHI Secretary for Archives, Dr. Edgar Godoy.

Evidence Check: Homeopathy

On 26 July 2010, the British Government responded to the Science and Technology (S&T) Committee report ‘Evidence Check2: Homeopathy'. The Government reaffirms that homeopathy belongs in the National Health Service (NHS) where patients can best benefit from doctors integrating it into healthcare. The response clearly states that ‘local NHS and clinicians, rather than Whitehall, are best placed to make decisions on what treatment is appropriate for their patients - including complementary or alternative treatments such as homeopathy - and provide accordingly for those treatments.'

Ljubljana/Slovenia, 8 April 2010

The Slovenian Homeopathic Society, the Liga Medicorum Homoeopathica Internationalis (LMHI) and the European Committee for Homeopathy (ECH) jointly organized the International Symposium on Homeopathy to celebrate the International Homeopathy Day and promote public awareness of homeopathy in Slovenia. The conference was held in Slovene and English, simultaneous interpretation was provided.

Download:
"Homeopathy – It's position in the world" - Speech by LMHI-President Dr. Ulrich D. Fischer

Interview with Dr. Irena Gorišek, President of the Slovenian Homeopathic Society and Slovenia’s NVP to the LMHI

The World Health Organization has just published "Safety issues in the preparation of homeopathic medicines".

Homeopathy is used worldwide, however, the national regulatory framework and the place of homeopathy within the health care system differ from country to country.

This technical document, published on 17 February 2010 (448 pages), is the WHO's response to requests and recommendations made by relevant World Health Assembly resolutions, by Member States, as well as international conferences of drug regulatory authorities, and is a part of the implementation of the WHO Traditional Medicine Strategy and the WHO Medicines Strategy.

Response by the European Committee for Homeopathy ECH and the International Homeopathic Medical League LMHI 

In a report published 22 February 2010, the Science and Technology Committee of the United Kingdom House of Commons concludes that homeopathy is not efficacious (that is, it does not work beyond the placebo effect), that explanations for why homeopathy would work are scientifically implausible and that further clinical trials of homeopathy could not be justified. Furthermore, it concludes that the NHS should cease funding homeopathy and that the Medicines and Healthcare products Regulatory Agency (MHRA) should no longer license homeopathic medicines.

Remarkably, just 4 of the 14 members of the Science and Technology Committee voted on this report: 3 for, one against. One of its three signatories has stridently campaigned against homeopathy and continued to do so even in the period between the hearings and the publication of the report.

The European Committee for Homeopathy ECH and the International Homeopathic Medical League LMHI find the conclusions and recommendations of the Science and Technology Committee completely unfounded. The report is highly tendentious and fundamentally flawed, consistently misrepresenting the scientific evidence to the detriment of homeopathy and making unfounded and pejorative allegations against those who advocate or practise homeopathy.

A recent study published in the International Journal of Oncology has demonstrated the beneficial effects of homeopathic medicines on breast cancer cells.

In 1999 the US National Cancer Institute (NCI) evaluated a cancer treatment protocol developed at the P. Banerji Homeopathic Research Foundation (PBHRF) in Kolkata, India. The ‘Banerji protocol’ used specific ultra-diluted natural substances to treat patients with different cancers. The NCI reviewed 10 patients treated on the Banerji protocol. In four of the cases with lung and esophageal cancers, the NCI confirmed partial responses. All patients reviewed had appropriate pathology and imaging studies to confirm diagnosis and response. The patients only received the remedies prescribed at the PBHRF clinic and did not receive any additional conventional treatment, such as surgery, radiation, or chemotherapy. After rigorous evaluation, the NCI concluded that there was sufficient evidence of efficacy to warrant further research of the Banerji protocol.

Re: "WHO warns against homeopathy use"

Letter from LMHI President Dr Ulrich D. Fischer to Dr Margaret Chan, the Director-General of the World Health Organization (WHO), regarding the WHO's position on homeopathic medicines.

Evidence Based Homeopathy

After 64rd LMHI Congress - 2009
Editor: LMHI and ECH secretary for research Dr Michel Van Wassenhoven.

This booklet is aimed at considering all important aspects of the scientific framework of Homeopathic practice including ethical questions, evaluation of daily practice, looking at the level of scientific evidence of each of these aspects. The conclusions are that homeopathy has to stay in the framework of medical practice and it is even a necessity for public health. Of course, more research is always necessary.

This booklet is a joint production of the Liga Medicorum Homeopathica Internationalis (LMHI) and of the European Committee for Homeopathy (ECH).

LMHI Guideline for Clinical Data Collection

Historically, homeopathy always acts very well in pandemic situations. To confirm this fact nowadays, homeopaths have to collect the clinical data of their influenza patients.

The first aim is to define the "genius epidemicus", first at the office of each MD, later on in each country and finally worldwide. Taking some time for this analysis is winning time for next consultations to everybody.
The second aim will be to have the possibility to do a retrospective survey on the pandemic situation when it will be passed.